Seeking Alpha

Chelsea Therapeutics tumbles as investors digest briefing docs

  • Briefing docs are out for next week's Northera (CHTP) Ad Com.
  • FDA staff list five arguments in favor of approval and seven against approval.
  • "The primary reason not to recommend approval is the lack of sufficient evidence of efficacy," the documents say.
  • Full documents
  • CHTP -21% premarket
Comments (1)
  • hneumann
    , contributor
    Comments (624) | Send Message
     
    Where on the FDA website todays Northera review can be found ?
    10 Jan 2014, 02:11 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs